Clinical Oncology
Volume 21, Issue 8 , Pages 598-609 , October 2009

Acute and Late Toxicity in Radical Radiotherapy for Bladder Cancer

  • W. Majewski

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: W. Majewski, Department of Radiotherapy, Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-100 Gliwice, Poland. Tel/Fax: +4832-278-80-01.
    • ,
  • R. Tarnawski

Received 14 October 2007 ,Revised 26 February 2009 ,Accepted 28 April 2009.

References 

  1. Cerevek J, Cufer T, Krageli B, Zakotnik B, Stanonik M. Sequential transurethral surgery, multiple drug chemotherapy, and radiation for invasive bladder carcinoma: initial report. Int J Radiat Oncol Biol Phys. 1993;25:777–782
  2. Coppin CML, Gospodarowicz MK, James K, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol. 1996;14:2901–2907
  3. Cowan RA, McBain CA, Ryder WDJ, et al. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:197–207
  4. Davidson SE, Symonds RP, Snee MP, Upadhyay S, Habeshaw T, Robertson AG. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol. 1990;66:288–293
  5. Duncan W, Quilty PM. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol. 1986;7:299–310
  6. Horwich A, Dearnaley D, Huddart R, et al. A randomised trial of accelerated radiotherapy for localized invasive bladder cancer. Radiother Oncol. 2005;75:34–43
  7. Majewski W, Maciejewski B, Majewski S, Suwinski R, Miszczyk L, Tarnawski R. Clinical radiobiology of stage T2–T3 bladder cancer. Int J Radiat Oncol Biol Phys. 2004;60:60–70
  8. Pollack A, Zagars GK, Swanson DA. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys. 1994;30:267–277
  9. Salminen E. External beam radiation treatment of urinary bladder carcinoma. Acta Oncol. 1990;29:909–914
  10. Shipley WU, Winter KA, Kaufman DS, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol. 1998;16:3576–3583
  11. Tester W, Caplan R, Heaney J, et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol. 1996;14:119–126
  12. Tonoli S, Bertoni F, de Stefani A, et al. Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. Clin Oncol (R Coll Radiol). 2006;18:52–59
  13. Cole DJ, Durrant KR, Roberts JT, Dawes JTK, Yosef H, Hopewell W. A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol. 1992;65:792–798
  14. Moonen L, van der Voet H, Horenblas S, Bartelink H. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys. 1997;37:537–542
  15. Joiner MC, Bentzen SM. Time–dose relationships: the linear-quadratic approach. In:  Steel GG editors. Basic clinical radiobiology. London: Arnold; 2002;
  16. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187–220
  17. Bentzen SM, Saunders MI, Dische S, Bond SJ. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol. 2001;60:123–135
  18. Denham JW, Hauer-Jensen M. The radiotherapeutic injury–a complex wound. Radiother Oncol. 2002;63:129–145
  19. Hainau B, Dombernowsky P. Histology and cell proliferation in human bladder tumors. Cancer. 1974;33:115–126
  20. Stewart FA. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer. 1986;53:280–291
  21. Dorr W, Eckhardt M, Ehme A, Koi S. Pathogenesis of acute radiation effects in the urinary bladder. Strahlenther Oncol. 1998;174(Suppl III):93–95
  22. Denham JW, Hauer-Jensen M, Kron T, Langberg CW. Treatment-time-dependence models of early and delayed radiation injury in rat small intestine. Int J Radiat Oncol Biol Phys. 2000;48:871–887
  23. Cox JD, Guse C, Asbell S, Rubin P, Sause WT. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of protocol 83-08 of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1988;15:1331–1336
  24. Morrison R. The results of treatment of cancer of the bladder – a clinical contribution to radiobiology. Clin Radiol. 1975;26:67–75
  25. Quilty PM, Duncan W, Kerr GR. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol. 1985;36:615–618
  26. Vijayakumar S, Awan A, Karrison T, et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. Int J Radiat Oncol Biol Phys. 1993;25:359–371
  27. Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 1999;85:2460–2468
  28. Schultheiss TE, Lee WR, Hunt MA, Hanlon AR, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:3–11
  29. Michalowski A. On radiation damage to normal tissues and its treatment. I Growth factors. Acta Oncol. 1990;29:1017–1023
  30. Williams J, Chen Y, Rubin P, Finkelstein J, Okunieff P. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:182–188
  31. Bentzen SM, Lundbeck F, Christensen LL, Overgaard J. Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder. Radiother Oncol. 1992;25:301–307
  32. Lievens Y, Vanuytsel L, Rijnders A, van Poppel H, van der Schueren E. The time course of development of late side effects after irradiation of the prostate with multiple fractions per day. Radiother Oncol. 1996;40:147–152
  33. van der Aardweg GJMJ, Hopewell JW. The kinetics of repair for sublethal radiation-induced damage in the pig epidermis: an interpretation based on a fast and slow component of repair. Radiother Oncol. 1992;23:94–104
  34. Plataniotis G, Michalopoulos E, Kouvaris J, Vlahos L, Papavasiliou C. A feasibility study of partially accelerated radiotherapy for invasive bladder cancer. Radiother Oncol. 1994;33:84–87
  35. Pos FJ, van Tienhoven G, Hulshof MCCM, Koedooder K, Gonzales DG. Concomitant boost radiotherapy for muscle-invasive bladder cancer. Radiother Oncol. 2003;68:75–80
  36. Yavuz AA, Yavuz MN, Ozgur GK, et al. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2003;56:734–745
  37. Pilepich MV, Krall JM, Sause WT, et al. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate – analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys. 1987;13:351–357
  38. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  39. Rubin P, Casarett G. A direction for clinical radiation pathology. The tolerance dose. Front Radiat Ther Oncol. 1972;6:1–16
  40. Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PMT, Harrison SCW. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol. 2003;43:246–257
  41. Fokdal L, Hoyer M, Meldgaard P, von der Maase H. Long-term bladder, colorectal and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol. 2004;72:139–145
  42. Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol. 2002;62:215–225
  43. Caffo O, Fellin G, Graffer U, Luciani L. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. Cancer. 1996;78:1089–1097

PII: S0936-6555(09)00144-7

doi: 10.1016/j.clon.2009.04.008

Clinical Oncology
Volume 21, Issue 8 , Pages 598-609 , October 2009

Article Tools

* Image Usage & Resolution